1. Synthesis of Flavone and Initiation with Cytochrome P4501A2 Acknowledgments : I would like to thank Holly Guevara, Deepthi Bhogadhi, and Professor Greenberg for guidance throughout this project, Dr. Stacia Sower for making her laboratory available to us and the Department of Chemistry for funding. Patrick Curley Department of Chemistry, University of New Hampshire, Durham, New Hampshire 03824 pbw9@wildcats.unh.edu Introduction Flavone is the backbone of an organic group of molecules known as flavonoids. These flavonoids are found naturally in many plants and have significant biomedical uses, as they have been shown to be metabolized by cytochrome P450. Flavonoids has been shown to act as an inhibitor in these reactions. 1 Flavone was synthesized as shown in Scheme 1 and then incubated with cytochrome P4501A2 to observe its possible inhibition properties. Scheme 1: Synthesis of Flavone References: 1.) Sridhar, Jayalakshmi; Ellis, Jamie; Dupart, Patrick; Liu, Jiawang; Stevens, Cheryl L; Foroozesh, Maryam; Drug Metab Lett. 2012; 6(4): 275–284. 2.) M. Hardwood; C.J. Moody; J.M. Percy. Experimental Organic Chemistry; Blackwell Science; Oxford, UK; 1999; Pgs 624-626 3.) Cho,TM; Rose, RL; Hodgson, E; Drug Metab Dispos. 2006 Jan; 34(1):176-83. Results and Discussion The first step was the benzoylation of the phenolic –OH group of the starting material 2-hydroxyacetophenone 1 to yield 2-benzoyloxyacetophenone 2. (84% yield) In the presence of potassium hydroxide and heat, 2 undergoes the Baker-Venkataraman rearrangement in order to form 2-hydroxydibenzoylmethane 3. 2 (91% yield) The cyclization of 3 in the presence of sulfuric and acetic acid yields the final product, flavone 4. (60% yield) Flavone was purified through recrystallization with hexanes and had melting point range of 96.6 ˚ C-97.9˚C. Mechanism 1: Baker-Venkataraman Rearrangement Conclusions: From the data obtained, it is clear that the incubation procedure must be edited in order to obtain accurate results. The enzyme could possibly be flawed, as the inconsistencies in data were present throughout all results. Future Work Since there is excess product left over from reactions, possible future work should include editing the incubation procedure and the concentrations of solutions in order to obtain conclusive results. If this is achieved, additional flavonoids could be synthesized from remaining product and inhibition experiments could be carried out to gain a further understanding of the interactions between human cytochrome P450 and flavonoids. Table 1: Preparation of Solutions for Inhibition of Flavone Results and Discussion: Flavone was incubated with cytochrome P4501A2 by following a procedure published in Drug Metabolism & Disposition 3. Naphthalene was chosen as a substrate for the reaction because it is metabolized by cytochrome P4501A2 and its metabolites are known. Expected results would be to see the metabolites of naphthalene present in the positive control and see the absence of naphthalene metabolites in the presence of flavone, as it is excpeted to inhibit the binding site of P4501A2 1 H NMR of Flavone Product 1 H NMR of Crude 2-hydroxydibenzoylmethane ReagentVolumes (µL) for.5 mL total volume Final Concentrations.5 M Phosphate Buffer100100mM Solution A251.3 mM NADP + 3.3 mM G6P 3.3 mM MgCl 2 Solution B5.4 U/mL G6PDH CYP 4501A2 (1pmol/µl)2550 pmol/mL WaterSee Below- Substrate (78 mM in MeCN)See Below300 µM Inhibitor (45mM in MeCN)See Below150 or 300µM Trial Name1A2 (+ control)1A2A1A2B1A2 (- control) Substrate Concentration 300 µM (1.9 µL) 300 µM (1.9 µL) 300 µM (1.9 µL) 0 µM (0 µL) Inhibitor Concentration 0 µM (0 µL) 300 µM (3.3 µL) 150 µM (1.6 µL) 300 µM (3.3 µL) Water343.1 µL339.8 µL341.5 µL341.7 µL After incubating for 15 minutes in a 37˚C water bath, the solutions were centrifuged and the organic layers were extracted and a gas chromatography/mass spectrometry spectrum was obtained. The chromatogram shows that the positive control of naphthalene shows no evidence of metabolites, which is unexpected. There are several unidentified compounds consistently present in each spectrum. This data suggests that there might be a problem with the procedure or the enzyme itself, as the peaks are consistent throughout the results.